Keyword Search
Legend:
CC = Vancouver Convention Centre F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: Subgroups returned 14 record(s)
|
|
Tuesday, 07/31/2018
|
Preventing False Discovery of Heterogeneous Treatment Effect Subgroups in Randomized Trials
Joseph Rigdon, Stanford University; Michael Baiocchi, Stanford University; Sanjay Basu, Stanford University School of Medicine
|
Analysis Framework in Integrating Data of Different Modalities with Application in Identifying Important Predictors/Subgroups in Non-Alcoholic Steatohepatitis
Tuan Nguyen, Gilead Sciences; Guang Chen, Gilead Sciences; Adarsh Joshi, Gilead Sciences, Inc.; Lulu Wang, Gilead Sciences; Yafeng Zhang, Gilead Sciences; Yuanyuan Xiao, Gilead Sciences; Catherine Jia, Gilead Sciences; Ren Xu, Gilead Sciences; Stephen Djedjos, Gilead Sciences; Rob Myers, Gilead Sciences
|
Subgroup Mixable Exact Simultaneous Confidence Intervals for Logical Selection of a CDx Cut-Point
Jason Hsu, Ohio State University
|
Improving the Standards for Reporting of Clinical Trial Data
Jitendra Ganju, Consultant
3:35 PM
|
|
Wednesday, 08/01/2018
|
A Latent Class Analysis to Identify Subgroups of Heart Failure Under Missingness And/Or Uncertainty in the Indicator Variables
Wendimagegn Alemayehu, University of Alberta; Cynthia M Westerhout, University of Alberta; Jason R Dyck, University of Alberta; Todd Anderson, University of Calgary; Justin A Ezekowitz, University of Alberta
|
Treatment Effect Estimation in Subgroups: a Comparative Study
Weihua Cao, Novartis Pharmaceutical Corp; Bjoern Holzhauer, Novartis Pharma AG; Steffen Ballerstedt, Novartis Pharma AG; Dong Xi, Novartis Pharmaceuticals; Ieuan Jones, Novartis Pharma AG
|
Multiplicity-Controlled Benefiting Subgroup Identification via Credible Subgroups
Patrick Schnell, Ohio State University; Qi Tang, Sanofi; Peter Müller, University of Texas Austin; Brad Carlin, University of Minnesota
8:35 AM
|
Treatment Effect Estimation in Subgroups: a Comparative Study
Weihua Cao, Novartis Pharmaceutical Corp; Bjoern Holzhauer, Novartis Pharma AG; Steffen Ballerstedt, Novartis Pharma AG; Dong Xi, Novartis Pharmaceuticals; Ieuan Jones, Novartis Pharma AG
8:50 AM
|
|
|
